acetaminophen 500 MG / caffeine 32.5 MG / phenylephrine hydrochloride 5 MG Oral Tablet
- RxCUI
- 1367210
- RxNorm name
- acetaminophen 500 MG / caffeine 32.5 MG / phenylephrine hydrochloride 5 MG Oral Tablet
- Term type
- SCD
- Status
- Active
- Updated
- 2026-07-26 06:59:21
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 022013
- Active start
- 022013
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
Ingredient, Strength, Base table| Ingredient | Strength | Base | Basis of strength |
|---|
| acetaminophen | 500 MG / 1 EACH | acetaminophen | acetaminophen |
| caffeine | 32.5 MG / 1 EACH | caffeine | caffeine |
| phenylephrine hydrochloride | 5 MG / 1 EACH | phenylephrine | phenylephrine hydrochloride |
Derived Ingredient Concepts#
RxNav Current And Historical NDCs#
RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances#
UNII substance links page 1 of 1 · 0 matching rows.
No records found.
DailyMed RxNorm Mappings#
unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.
No records found.
Drug Classes#
Source, Class ID, Class table| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|
| ATC | C01CA | Adrenergic and dopaminergic agents | ATC1-4 | | phenylephrine |
| ATC | N02BE | Anilides | ATC1-4 | | acetaminophen |
| ATC | C05AX | Other agents for treatment of hemorrhoids and anal fissures for topical use | ATC1-4 | | phenylephrine |
| ATC | D11AX | Other dermatologicals | ATC1-4 | | caffeine |
| ATC | R01BA | Sympathomimetics | ATC1-4 | | phenylephrine |
| ATC | S01FB | Sympathomimetics excl. antiglaucoma preparations | ATC1-4 | | phenylephrine |
| ATC | S01GA | Sympathomimetics used as decongestants | ATC1-4 | | phenylephrine |
| ATC | R01AB | Sympathomimetics, combinations excl. corticosteroids | ATC1-4 | | phenylephrine |
| ATC | R01AA | Sympathomimetics, plain | ATC1-4 | | phenylephrine |
| ATC | N06BC | Xanthine derivatives | ATC1-4 | | caffeine |
| FDASPL | D014970 | Xanthines | CHEM | has_chemical_structure | caffeine |
| FDASPL | N0000186105 | alpha-1 Adrenergic Agonist | EPC | has_epc | phenylephrine |
| FDASPL | N0000175739 | Central Nervous System Stimulant | EPC | has_epc | caffeine |
| FDASPL | N0000175790 | Methylxanthine | EPC | has_epc | caffeine |
| FDASPL | N0000175729 | Central Nervous System Stimulation | PE | has_pe | caffeine |
| MEDRT | D000082 | Acetaminophen | CHEM | has_ingredient | acetaminophen |
| MEDRT | D002110 | Caffeine | CHEM | has_ingredient | caffeine |
| MEDRT | D010656 | Phenylephrine | CHEM | has_ingredient | phenylephrine |
| MEDRT | D010656 | Phenylephrine | CHEM | has_ingredient | phenylephrine hydrochloride |
| MEDRT | D013447 | Sulfites | CHEM | ci_chemclass | phenylephrine |
| MEDRT | D013447 | Sulfites | CHEM | ci_chemclass | phenylephrine hydrochloride |
| MEDRT | D001049 | Apnea | DISEASE | may_treat | caffeine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | phenylephrine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | acetaminophen |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | caffeine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | phenylephrine hydrochloride |
| MEDRT | D005221 | Fatigue | DISEASE | may_treat | caffeine |
| MEDRT | D005334 | Fever | DISEASE | may_treat | acetaminophen |
| MEDRT | D005334 | Fever | DISEASE | may_prevent | acetaminophen |
| MEDRT | D005401 | Fissure in Ano | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D005401 | Fissure in Ano | DISEASE | may_treat | phenylephrine |
| MEDRT | D005902 | Glaucoma, Open-Angle | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D005902 | Glaucoma, Open-Angle | DISEASE | may_treat | phenylephrine |
| MEDRT | D005955 | Glucosephosphate Dehydrogenase Deficiency | DISEASE | ci_with | acetaminophen |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | phenylephrine |
| MEDRT | D006973 | Hypertension | DISEASE | ci_with | phenylephrine |
| MEDRT | D006973 | Hypertension | DISEASE | ci_with | phenylephrine hydrochloride |
| MEDRT | D007022 | Hypotension | DISEASE | may_treat | phenylephrine |
| MEDRT | D007022 | Hypotension | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | acetaminophen |
| MEDRT | D015878 | Mydriasis | DISEASE | induces | phenylephrine |
| MEDRT | D015878 | Mydriasis | DISEASE | induces | phenylephrine hydrochloride |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | acetaminophen |
| MEDRT | D010146 | Pain | DISEASE | may_treat | acetaminophen |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | phenylephrine |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D012223 | Rhinitis, Vasomotor | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D012223 | Rhinitis, Vasomotor | DISEASE | may_treat | phenylephrine |
| MEDRT | D012772 | Shock, Septic | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D012772 | Shock, Septic | DISEASE | may_treat | phenylephrine |
| MEDRT | D013617 | Tachycardia, Supraventricular | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D013617 | Tachycardia, Supraventricular | DISEASE | may_treat | phenylephrine |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | ci_with | phenylephrine hydrochloride |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | ci_with | phenylephrine |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | phenylephrine hydrochloride |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | phenylephrine |
| MEDRT | N0000000133 | Enzyme Inhibitors | MOA | has_moa | caffeine |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | acetaminophen |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | caffeine |
| MEDRT | N0000008331 | Cardiovascular Activity Alteration | PE | has_pe | caffeine |
| MEDRT | N0000175724 | Central Nervous System Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | phenylephrine hydrochloride |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | phenylephrine |
| MEDRT | N0000008567 | Decreased Collecting Duct Water Permeability | PE | has_pe | caffeine |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | phenylephrine hydrochloride |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | phenylephrine |
| MEDRT | N0000008836 | Decreased Prostaglandin Production | PE | has_pe | acetaminophen |
| MEDRT | N0000009072 | Hypothalamic Endocrine Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000009197 | Increased Central Nervous System Organized Electrical Activity | PE | has_pe | caffeine |
| MEDRT | N0000175725 | Peripheral Nervous System Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | acetaminophen |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | acetaminophen |
Properties#
Category, Property, Value table| Category | Property | Value |
|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| NAMES | Prescribable Synonym | acetaminophen 500 MG / caffeine 32.5 MG / phenylephrine HCl 5 MG Oral Tablet |
| SOURCES | Source | Micromedex RED BOOK |